Scientists unlock the genetic switch controlling cannabis chemistry

The Structure of the Chemotype Determining Locus in Cannabis sativa.

Plant direct • • Moderately Relevant
🤖

AI Summary

Scientists have finally cracked the genetic code behind cannabis chemistry. Researchers discovered that the "B locus"—a specific region in the cannabis genome—functions as a supergene that acts like a genetic switch, determining whether a plant produces high-CBD or high-THC chemotypes. This locus contains two tightly linked genes (THCAS and CBDAS) with suppressed recombination between them, which explains why the trait behaves like a simple on-off genetic switch despite being controlled by multiple genes. This finding solves a long-standing puzzle in cannabis biology: how plants can stably maintain distinct chemical profiles across generations while following simple Mendelian inheritance patterns.

The research reveals surprising genetic complexity within the B locus, including substantial structural variations, gene copy number differences, and large-scale DNA insertions and deletions across cannabis varieties. Scientists also functionally characterized three previously unknown enzymes in the cannabinoid oxidocyclase family, confirming that cannabinoid profiles are specifically determined by which enzyme (THCAS or CBDAS) is present and active. Additionally, researchers mapped the expression patterns of the berberine bridge enzyme family across plant tissues, including the glandular trichomes that produce cannabinoids.

These discoveries establish a fundamental framework for understanding cannabis genetics and have immediate practical implications. Breeders can now identify and select for specific chemotypes more precisely, potentially developing plants with optimized cannabinoid ratios for medical applications. The findings also illuminate how cannabis evolved its remarkable chemical diversity—a result of selective pressures that maintained distinct chemotypes rather than allowing them to blend together.

📄 Original Abstract

The chemical phenotype (chemotype) of Cannabis sativa is defined by the ratio of cannabidiolic acid (CBDA) to Δ9-tetrahydrocannabinolic acid (THCA). Although the Mendelian segregation of these traits suggests a single-locus biallelic system, recent sequencing and phylogenetic evidence indicate they are encoded by two distinct, tightly linked genes. The precise genomic architecture of this region, known as the B locus, has remained poorly defined. In this study, we analyzed recently released high-quality Cannabis reference genomes to resolve the structure of the B locus. Our results demonstrate that this region functions as a supergene, characterized by suppressed recombination that facilitates Mendelian-like switching between phenotypic states. Comparative genomic analysis reveals substantial structural polymorphism within the locus, including significant variations in gene copy number and large-scale insertions/deletions (indels). Furthermore, we functionally characterized three previously unstudied members of the cannabinoid oxidocyclase family. We find that these enzymes primarily catalyze the production of cannabichromenic acid (CBCA), reinforcing the model that cannabinoid profile is dictated specifically by the presence and expression of THCAS or CBDAS. Finally, we mapped the expression profile of the entire berberine bridge enzyme (BBE) family, identifying widespread expression across plant tissues, including in glandular trichomes. Collectively, these findings resolve the genomic architecture of the B locus, clarify the enzymatic basis of cannabinoid profile determination, and establish a framework for understanding the evolutionary maintenance of chemotype diversity in C. sativa.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.